Agenus Forecasts $2.10 EPS, 438% Revenue Jump Ahead of Q1 Report
AGEN sits 43% above its 52-week low of $2.71 on light trading volume (0.3× avg).
Summary
Agenus Inc. is expected to report a significant financial turnaround for the quarter ending March 31, 2026, with analysts forecasting earnings of $2.10 per share and a substantial 438.1% year-over-year revenue increase to $129.5 million. This highly positive earnings preview is particularly notable given the company's recent 10-K filing on March 16, 2026, which raised substantial doubt about its ability to continue as a going concern. While the mean earnings estimate has seen a modest 1.0% decline over the last three months, the magnitude of the anticipated revenue growth and positive EPS represents a potential major shift in the company's financial trajectory. Traders will be keenly focused on the actual earnings release on May 11 to see if these strong expectations are met, as confirmation could significantly re-rate the stock and alleviate prior financial concerns.
At the time of this announcement, AGEN was trading at $3.88 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $148.9M. The 52-week trading range was $2.71 to $7.34. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.